Agilent Joins Picometrics in Biopharma Deal
SANTA CLARA, Calif. & LABEGE, France, Jan. 21, 2014 — Agilent Technologies Inc. and Picometrics Technologies have signed a co-marketing agreement to improve efficiency in the research and development of complex large-molecule biopharmaceutical compounds.
Analysis technology tools such as capillary electrophoresis (CE), laser-induced fluorescence (LIF) detection and mass spectrometry are particularly useful for the research and development of new biological entities, said Michael Frank, marketing director of liquid phase separations at Agilent.
“As conventional drug research becomes outmoded in meeting the increasing demands of complex, large-molecule drug development, scientists need highly sophisticated tools like these to advance therapeutic discovery,” Frank said.
Several Agilent products can be used with Picometrics’ Zetalif LED and Zetalif Laser instruments, including Agilent’s CE and CE/mass spectrometry technologies, as well as HPLC/UHPLC (high-performance liquid chromatography / ultrahigh-pressure liquid chromatography) solutions.
For more information, visit: www.agilent.com or www.picometrics.com